549 related articles for article (PubMed ID: 26115054)
21. [Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].
Dordević V; Rakićević L; Spasić M; Miković D; Kovać M; Radojković D
Vojnosanit Pregl; 2005 Mar; 62(3):201-5. PubMed ID: 15790048
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
Couto E; Nomura ML; Barini R; Pinto e Silva JL
Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss.
Borsi E; Potre O; Ionita I; Samfireag M; Secosan C; Potre C
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674167
[No Abstract] [Full Text] [Related]
25. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
[TBL] [Abstract][Full Text] [Related]
27. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Marchiori A; Mosena L; Prins MH; Prandoni P
Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
[TBL] [Abstract][Full Text] [Related]
28. Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals.
Lim MY; Deal AM; Kim S; Musty MD; Conard J; Simioni P; Dutrillaux F; Eid SS; Middeldorp S; Halbmayer WM; Boneu B; Moia M; Moll S
Eur J Haematol; 2016 Oct; 97(4):353-60. PubMed ID: 26773706
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
[TBL] [Abstract][Full Text] [Related]
30. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.
Grandone E; Margaglione M; Colaizzo D; D'Andrea G; Cappucci G; Brancaccio V; Di Minno G
Am J Obstet Gynecol; 1998 Nov; 179(5):1324-8. PubMed ID: 9822524
[TBL] [Abstract][Full Text] [Related]
31. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
[TBL] [Abstract][Full Text] [Related]
32. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
[TBL] [Abstract][Full Text] [Related]
33. Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.
Kupeli E; Verdi H; Simsek A; Atac FB; Eyuboglu FO
Clin Appl Thromb Hemost; 2011; 17(6):E87-94. PubMed ID: 21078611
[TBL] [Abstract][Full Text] [Related]
34. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.
Ho WK; Hankey GJ; Quinlan DJ; Eikelboom JW
Arch Intern Med; 2006 Apr; 166(7):729-36. PubMed ID: 16606808
[TBL] [Abstract][Full Text] [Related]
35. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2011 Jan; 13(1):67-76. PubMed ID: 21150787
[TBL] [Abstract][Full Text] [Related]
36. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
37. Role of thrombotic risk factors in end-stage renal disease.
Tripathi G; Sankhwar SN; Sharma RK; Baburaj VP; Agrawal S
Clin Appl Thromb Hemost; 2010 Apr; 16(2):132-40. PubMed ID: 19520684
[TBL] [Abstract][Full Text] [Related]
38. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
40. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
Gohil R; Peck G; Sharma P
Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
